21 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

Guardion Health Sciences, Inc. GHSI stock rose 10.6% to $0.81 during Friday's pre-market session.
Precipio, Inc. PRPO shares moved upwards by 8.6% to $3.55. The market cap seems to be at $14.0 million.
Applied Genetic Tech, Inc. AGTC shares surged 8.2% to $4.33. The market cap stands at $68.1 million. The most recent rating by BMO Capital, on September 27, is at Outperform, with a price target of $9.00.
Plus Therapeutics, Inc. PSTV stock increased by 7.9% to $3.56. The market cap stands at $1.7 million.
Intec Pharma, Inc. NTEC stock moved upwards by 7.1% to $0.74. The market value of their outstanding shares is at $28.4 million. According to the most recent rating by H.C. Wainwright, on August 07, the current rating is at Neutral.
Aduro Biotech, Inc. ADRO shares moved upwards by 5.7% to $1.12. The market cap stands at $260.1 million.
Sienna Biopharmaceuticals, Inc. SNNA stock increased by 4.9% to $0.12. The market value of their outstanding shares is at $3.4 million. The most recent rating by BMO Capital, on September 05, is at Outperform, with a price target of $3.00.
Sesen Bio, Inc. SESN stock moved upwards by 4.5% to $1.15. The market value of their outstanding shares is at $67.6 million.
Xenetic Biosciences, Inc. XBIO shares moved upwards by 4.3% to $1.45. The market value of their outstanding shares is at $7.6 million.
Restoration Robotics, Inc. HAIR stock increased by 3.3% to $0.62. The market cap stands at $24.8 million.
Sundial Growers, Inc. SNDL stock moved upwards by 2.2% to $4.55. The market cap seems to be at $582.3 million. The most recent rating by BMO Capital, on September 10, is at Outperform, with a price target of $12.00.
Pluristem Therapeutics, Inc. PSTI stock surged 2.1% to $3.96. The market value of their outstanding shares is at $63.5 million.
VBI Vaccines, Inc. VBIV shares surged 2.0% to $0.52. The market cap seems to be at $51.5 million.

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Losers

Atara Biotherapeutics, Inc. ATRA shares declined 14.9% to $11.55 during Friday's pre-market session. The market cap seems to be at $791.8 million. The most recent rating by Goldman Sachs, on September 27, is at Sell, with a price target of $9.00.
Histogenics, Inc. HSGX stock declined 13.9% to $0.20. The market cap seems to be at $20.8 million.
Ra Medical Systems, Inc. RMED shares declined 4.4% to $1.31. The market value of their outstanding shares is at $17.5 million. The most recent rating by Piper Jaffray, on August 13, is at Neutral, with a price target of $1.50.
Royal Philips, Inc. PHG shares plummeted 3.5% to $46.42. The market cap seems to be at $35.7 billion.
Takeda Pharmaceutical, Inc. TAK shares fell 2.8% to $17.30. The market cap seems to be at $55.3 billion.
Achillion Pharmaceuticals, Inc. ACHN stock fell 2.7% to $3.55. The market cap stands at $503.5 million.
Canopy Growth, Inc. CGC shares declined 2.4% to $24.15. The market cap seems to be at $8.3 billion. According to the most recent rating by Bank of America, on September 27, the current rating is at Neutral.
Marinus Pharmaceuticals, Inc. MRNS shares fell 2.4% to $1.65. The market cap seems to be at $66.7 million. The most recent rating by H.C. Wainwright, on September 03, is at Buy, with a price target of $5.00.